NCT06613126 Effectiveness of Symptom Management Application on Parental Care Ability of Children With Tourette Syndrome
| NCT ID | NCT06613126 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taipei University of Nursing and Health Sciences |
| Condition | Tourette Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2024-09-25 |
| Primary Completion | 2025-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2024-09-25 with a primary completion date of 2025-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study developed a Tourette Syndrome (TS) symptom management application (APP) to improve the care needs, sleep quality, anxiety, quality of life, and parenting relationship of parents of children with Tourette Syndrome.
Eligibility Criteria
Inclusion Criteria: 1. Parents of children between 6-12 years old who are diagnosed with Tourette Syndrome by pediatricians. 2. Parents who are the primary caregivers 3. Parents with normal cognitive functioning who can communicate in Mandarin. Exclusion Criteria: 1\. Children with Tourette Syndrome who are suffering from intellectual disability or critical diseases.
Contact & Investigator
Mei-Yin Lee, PhD
PRINCIPAL INVESTIGATOR
National Taipei University of Nursing and Health Sciences
Frequently Asked Questions
Who can join the NCT06613126 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 60 Years, studying Tourette Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06613126 currently recruiting?
Yes, NCT06613126 is actively recruiting participants. Contact the research team at meiyin0304@ntunhs.edu.tw for enrollment information.
Where is the NCT06613126 trial being conducted?
This trial is being conducted at Taoyuan City, Taiwan.
Who is sponsoring the NCT06613126 clinical trial?
NCT06613126 is sponsored by National Taipei University of Nursing and Health Sciences. The principal investigator is Mei-Yin Lee, PhD at National Taipei University of Nursing and Health Sciences. The trial plans to enroll 180 participants.